Fortschritt Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-05-2024
- Paid Up Capital ₹ 0.50 M
as on 30-05-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 30-05-2024
- Revenue 29.43%
(FY 2023)
- Profit 38.39%
(FY 2023)
- Ebitda 42.87%
(FY 2023)
- Net Worth 29.58%
(FY 2023)
- Total Assets -9.75%
(FY 2023)
About Fortschritt Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 Cr.
Anita Rawat, Naveen Chander, and Geeta Kandpal serve as directors at the Company.
- CIN/LLPIN
U24200HP2016PLC006253
- Company No.
006253
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Fortschritt Healthcare Limited offer?
Fortschritt Healthcare Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Nutritional Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Fortschritt Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Chander  | Director | 21-Jun-2016 | Current |
| Anita Rawat | Director | 21-Jun-2016 | Current |
| Geeta Kandpal | Director | 05-Aug-2020 | Current |
Financial Performance of Fortschritt Healthcare.
Fortschritt Healthcare Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.43% increase. The company also saw a substantial improvement in profitability, with a 38.39% increase in profit. The company's net worth Soared by an impressive increase of 29.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortschritt Healthcare?
In 2023, Fortschritt Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Feb 2022 | ₹2.00 Cr | Open |
How Many Employees Work at Fortschritt Healthcare?
Fortschritt Healthcare has a workforce of 12 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortschritt Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortschritt Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
